Megan E. Capozzi
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Ophthalmology top 2%
- Retinal Diseases and Treatments
Papers in
-
- Diabetes Treatment and Management 17
-
- Retinal Diseases and Treatments 11
- Co-authors
- Jonathan E. Campbell (18 shared papers)David A. D’Alessio (14 shared papers)John S. Penn (19 shared papers)Brian Finan (5 shared papers)Gary W. McCollum (11 shared papers)Berit Svendsen (5 shared papers)Kyle W. Sloop (5 shared papers)Jonathan D. Douros (4 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (6 papers)Diabetes (6 papers)Scientific Reports (5 papers)JCI Insight (4 papers)Cell Metabolism (3 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Megan E. Capozzi
41 papers receiving 2.0k citations
Megan E. Capozzi's Hit Papers
Peers
Comparison fields: 5 of 95
- Endocrinology, Diabetes and Metabolism 992
- Ophthalmology 201
- Surgery 738
- Endocrine and Autonomic Systems 82
- Pharmacology 193
Countries citing papers authored by Megan E. Capozzi
This map shows the geographic impact of Megan E. Capozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan E. Capozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan E. Capozzi more than expected).
Fields of papers citing papers by Megan E. Capozzi
This network shows the impact of papers produced by Megan E. Capozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan E. Capozzi. The network helps show where Megan E. Capozzi may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan E. Capozzi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist Hit paper breakdown → | 2020 | 381 |
| 2 | 2019 | 186 | |
| 3 | 2019 | 126 | |
| 4 | 2018 | 122 | |
| 5 | 2020 | 110 | |
| 6 | 2021 | 95 | |
| 7 | 2019 | 94 | |
| 8 | 2017 | 80 | |
| 9 | 2022 | 68 | |
| 10 | 2020 | 65 | |
| 11 | 2019 | 56 | |
| 12 | 2020 | 51 | |
| 13 | 2014 | 44 | |
| 14 | 2016 | 41 | |
| 15 | 2014 | 39 | |
| 16 | 2014 | 36 | |
| 17 | 2020 | 32 | |
| 18 | 2018 | 30 | |
| 19 | 2021 | 29 | |
| 20 | 2014 | 28 |
About Megan E. Capozzi
Megan E. Capozzi is a scholar working on Endocrinology, Diabetes and Metabolism, Ophthalmology, Surgery, Molecular Biology and Biochemistry, having authored 42 papers that have together received 2.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (17 papers), Pancreatic function and diabetes (16 papers), Retinal Diseases and Treatments (11 papers), Metabolism, Diabetes, and Cancer (5 papers), Retinal Development and Disorders (5 papers), Retinopathy of Prematurity Studies (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (992 citations), Ophthalmology (201 citations), Surgery (738 citations), Endocrine and Autonomic Systems (82 citations) and Pharmacology (193 citations). Megan E. Capozzi has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Jonathan E. Campbell, David A. D’Alessio, John S. Penn, Brian Finan, Gary W. McCollum, Berit Svendsen, Kyle W. Sloop, Jonathan D. Douros, MATTHEW J. MERRINS and Richard D. DiMarchi. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Diabetes, Scientific Reports, JCI Insight and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.